Tonix Pharmaceuticals Holding Corp (TNXP)
0.16
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 16:00
0.1587
0.00 (0.00%)
Pre-Market: 20:00
Tonix Pharmaceuticals Cash from Financing (TTM): 36.52M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.52M |
| September 30, 2023 | 3.032M |
| June 30, 2023 | -7.867M |
| March 31, 2023 | 63.28M |
| December 31, 2022 | 87.84M |
| September 30, 2022 | 124.38M |
| June 30, 2022 | 166.97M |
| March 31, 2022 | 116.84M |
| December 31, 2021 | 212.49M |
| September 30, 2021 | 208.58M |
| June 30, 2021 | 190.69M |
| March 31, 2021 | 203.06M |
| December 31, 2020 | 123.10M |
| September 30, 2020 | 91.16M |
| June 30, 2020 | 75.61M |
| March 31, 2020 | 41.60M |
| December 31, 2019 | 12.92M |
| September 30, 2019 | 22.19M |
| June 30, 2019 | 20.57M |
| March 31, 2019 | 23.08M |
| December 31, 2018 | 23.54M |
| September 30, 2018 | 7.47M |
| June 30, 2018 | 4.581M |
| March 31, 2018 | 17.95M |
| December 31, 2017 | 18.52M |
| Date | Value |
|---|---|
| September 30, 2017 | 22.26M |
| June 30, 2017 | 26.12M |
| March 31, 2017 | 21.60M |
| December 31, 2016 | 20.50M |
| September 30, 2016 | 15.64M |
| June 30, 2016 | 30.48M |
| March 31, 2016 | 18.64M |
| December 31, 2015 | 47.69M |
| September 30, 2015 | 48.00M |
| June 30, 2015 | 36.67M |
| March 31, 2015 | 36.86M |
| December 31, 2014 | 53.22M |
| September 30, 2014 | 57.24M |
| June 30, 2014 | 60.09M |
| March 31, 2014 | 60.36M |
| December 31, 2013 | 14.95M |
| September 30, 2013 | 13.88M |
| June 30, 2013 | 3.661M |
| March 31, 2013 | 3.255M |
| December 31, 2012 | 7.493M |
| September 30, 2012 | 5.739M |
| June 30, 2012 | 6.283M |
| March 31, 2012 | 6.548M |
| December 31, 2011 | 2.613M |
| September 30, 2011 | 2.502M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-7.867M
Minimum
Jun 2023
212.49M
Maximum
Dec 2021
94.37M
Average
87.84M
Median
Dec 2022
Cash from Financing (TTM) Benchmarks
| ACADIA Pharmaceuticals Inc | 25.13M |
| PetVivo Holdings Inc | 7.305M |
| Acurx Pharmaceuticals Inc | -- |
| Kezar Life Sciences Inc | 0.638M |
| Allakos Inc | 2.528M |